Published in Curr Issues Intest Microbiol on March 01, 2003
Antibiotics for the Treatment of Ulcerative Colitis | NCT00355602
The microbiome in infectious disease and inflammation. Annu Rev Immunol (2012) 3.76
Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A (2005) 2.08
Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut (2004) 1.63
Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One (2011) 1.26
Microbial induction of immunity, inflammation, and cancer. Front Physiol (2011) 1.20
Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration. J Clin Microbiol (2012) 1.04
Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. Gut (2005) 0.98
Impacts of gut bacteria on human health and diseases. Int J Mol Sci (2015) 0.97
Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol (2010) 0.96
The Role of Antibiotics in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2005) 0.92
Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model. Dig Dis Sci (2009) 0.86
Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis. J Clin Microbiol (2011) 0.86
Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol (2007) 0.85
Probiotics and inflammatory bowel diseases. Postgrad Med J (2006) 0.84
The immunology of the vermiform appendix: a review of the literature. Clin Exp Immunol (2016) 0.83
Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut (2004) 0.83
Human inflammatory bowel disease does not associate with Lawsonia intracellularis infection. BMC Microbiol (2006) 0.81
Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis. Scientifica (Cairo) (2016) 0.75
Acetate kinase Activity and Kinetic Properties of the Enzyme in Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9 Intestinal Bacterial Strains. Open Microbiol J (2014) 0.75
Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases. Front Immunol (2017) 0.75
Model-based Characterization of the Parameters of Dissimilatory Sulfate Reduction Under the Effect of Different Initial Density of Desulfovibrio piger Vib-7 Bacterial Cells. Open Microbiol J (2015) 0.75
PCR Conditions for 16S Primers for Analysis of Microbes in the Colon of Rats. J Biomol Tech (2016) 0.75
Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis. Gut Pathog (2017) 0.75
Apoptosis inhibitor expressed by macrophages tempers autoimmune colitis and the risk of colitis-based carcinogenesis in TCRalpha-/- mice. J Clin Immunol (2007) 0.75
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 6.61
The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol (1991) 4.29
Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol (1988) 2.71
Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol (2002) 2.18
Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut (1990) 2.13
Starch utilization by the human large intestinal microflora. J Appl Bacteriol (1986) 2.05
Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut (1993) 2.05
Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol (1988) 1.97
Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol (2008) 1.91
Protein degradation by human intestinal bacteria. J Gen Microbiol (1986) 1.90
Risk-perception: differences between adolescents and adults. Health Psychol (1995) 1.76
Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol (1996) 1.72
Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut (2004) 1.63
Prebiotic digestion and fermentation. Am J Clin Nutr (2001) 1.62
Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther (2006) 1.59
Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther (2013) 1.54
Role of intestinal bacteria in nutrient metabolism. JPEN J Parenter Enteral Nutr (1998) 1.54
Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol (1988) 1.53
Variation in human intestinal microbiota with age. Dig Liver Dis (2002) 1.41
Colonic microflora: nutrition and health. Nutrition (1997) 1.39
Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl (1997) 1.37
Inflammatory disease processes and interactions with nutrition. Br J Nutr (2009) 1.34
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut (2004) 1.26
Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. J Appl Bacteriol (1990) 1.22
Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol (1998) 1.16
Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. J Appl Microbiol (2010) 1.11
Prosody as an interactional resource: turn-projection and overlap. Lang Speech (2000) 1.11
Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteria. J Appl Microbiol (1998) 1.09
Gastrointestinal effects of prebiotics. Br J Nutr (2002) 1.08
Toxin synthesis and mucin breakdown are related to swarming phenomenon in Clostridium septicum. Infect Immun (2001) 1.08
The gut microbiota in inflammatory bowel disease. Curr Pharm Des (2009) 1.08
Studies on the proteolytic activity of Bacteroides fragilis. J Gen Microbiol (1988) 1.06
Dissimilatory amino Acid metabolism in human colonic bacteria. Anaerobe (1997) 1.02
Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol (1989) 1.02
Chemostat enrichments of human feces with resistant starch are selective for adherent butyrate-producing clostridia at high dilution rates. Appl Environ Microbiol (2000) 0.99
Ecthyma gangrenosum: an important feature of pseudomonal sepsis in a previously well child. Clin Exp Dermatol (2009) 0.96
Effect of nitrate on methane production and fermentation by slurries of human faecal bacteria. J Gen Microbiol (1988) 0.95
Digestive fates of soluble polysaccharides from marine macroalgae: involvement of the colonic microflora and physiological consequences for the host. J Appl Bacteriol (1996) 0.95
Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease. Aliment Pharmacol Ther (2010) 0.95
Estimation of the fermentability of dietary fibre in vitro: a European interlaboratory study. Br J Nutr (1995) 0.95
Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther (2013) 0.94
Comparison of carbohydrate substrate preferences in eight species of bifidobacteria. FEMS Microbiol Lett (1991) 0.94
Transport and metabolism of glucose and arabinose in Bifidobacterium breve. Arch Microbiol (1993) 0.94
Arabinogalactan utilization in continuous cultures of Bifidobacterium longum: effect of co-culture with Bacteroides thetaiotaomicron. Anaerobe (1995) 0.93
Difficulties in the neonatal diagnosis of Menkes' kinky hair syndrome--trichopoliodystrophy. Clin Pediatr (Phila) (1984) 0.93
Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system. Scand J Gastroenterol Suppl (1997) 0.92
Mucosal bacteria in ulcerative colitis. Br J Nutr (2005) 0.92
Consequences of biofilm and sessile growth in the large intestine. Adv Dent Res (1997) 0.92
Regulation of protease production in Clostridium sporogenes. Appl Environ Microbiol (1990) 0.91
Physiological and nutritional factors affecting synthesis of extracellular metalloproteases by Clostridium bifermentans NCTC 2914. Appl Environ Microbiol (1992) 0.90
Dissimilatory nitrate reduction by Propionibacterium acnes. Appl Environ Microbiol (1989) 0.89
Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol (1998) 0.87
Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens. Appl Environ Microbiol (1989) 0.86
Quantitative estimates of fermentation in the hind gut of man. Acta Vet Scand Suppl (1989) 0.86
Factors affecting fermentation reactions in the large bowel. Proc Nutr Soc (1993) 0.85
Bacterial milieu and mucosal bacteria in ulcerative colitis. Novartis Found Symp (2004) 0.85
Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro. J Med Microbiol (2001) 0.85
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. Int J Geriatr Psychiatry (2003) 0.85
Characterization of proteases formed by Bacteroides fragilis. J Gen Microbiol (1988) 0.83
Starch utilization by Bacteroides ovatus isolated from the human large intestine. Curr Microbiol (1997) 0.81
Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease. J Clin Neurosci (2005) 0.81
Informed consent. British institutions collaborating in projects overseas may face dilemma. BMJ (1997) 0.80
Carbohydrate utilization patterns and substrate preferences in Bacteroides thetaiotaomicron. Anaerobe (1995) 0.80
Asparagine and glutamine metabolism in Rhodopseudomonas acidophila. Arch Microbiol (1980) 0.80
Growth, incidence and activities of dissimilatory sulfate-reducing bacteria in the human oral cavity. FEMS Microbiol Lett (1995) 0.80
Co-culture of Bifidobacterium adolescentis and Bacteroides thetaiotaomicron in arabinogalactan-limited chemostats: effects of dilution rate and pH. Anaerobe (1995) 0.79
Growth of mucin degrading bacteria in biofilms. Methods Mol Biol (2000) 0.79
Needs assessment in continuing medical education. Its feasibility and value in a seminar about skin cancer for general practitioners. Med J Aust (1993) 0.79
The influence of the plasma inorganic iodine concentration on thyroid function in dehalogenase deficiency. Acta Endocrinol (Copenh) (1967) 0.78
Characterization of a chondroitin sulfate proteoglycan synthesized by monkey arterial smooth muscle cells in vitro. Connect Tissue Res (1992) 0.78
Utilization of starch and synthesis of a combined amylase/alpha-glucosidase by the human colonic anaerobe Bacteroides ovatus. J Appl Microbiol (1997) 0.77
The semi-permeability of silicone: a saline-filled breast implant with intraluminal and pericapsular Aspergillus flavus. J Plast Reconstr Aesthet Surg (2006) 0.77
A role for intestinal mycoplasmas in the aetiology of Crohn's disease? J Appl Microbiol (2002) 0.77
Formation of a dipeptidyl arylamidase by Bacteroides splanchnicus NCTC 10825 with specificities towards glycylprolyl-x and valylalanine-x substrates. J Med Microbiol (1997) 0.77
Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota. Benef Microbes (2015) 0.76
Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3(1/2) years duration. Int J Geriatr Psychiatry (2010) 0.76
Methodology for the evaluation of the Stephanie Alexander Kitchen Garden program. Health Promot J Austr (2013) 0.75
High incidence of treatment failure with vincristine, etoposide, epirubicin, and prednisolone chemotherapy with successful salvage in childhood Hodgkin disease. Med Pediatr Oncol (1999) 0.75
A case of verbal auditory agnosia: missing the word ... missing the sound.... Int J Lang Commun Disord (1998) 0.75
Degradative activities of gut anaerobes studied in a three-stage continuous culture model of the colon. Clin Infect Dis (1993) 0.75
Here come the needle ladies. Can Nurse (1989) 0.75
Physiology and biochemistry of glycyl-prolyl aminopeptidase formation in Bacteroides splanchnicus. Clin Infect Dis (1993) 0.75